October 29 | Suzhou Dr. Feng Ren, Co-CEO and Chief Scientific Officer of Insilico Medicine, has been invited to attend the 6th SAPA-China 2026 Healthcare Industry Conference at the Suzhou Shishan International Conference Center. (IMAGE)

InSilico Medicine

October 29 | Suzhou Dr. Feng Ren, Co-CEO and Chief Scientific Officer of Insilico Medicine, has been invited to attend the 6th SAPA-China 2026 Healthcare Industry Conference at the Suzhou Shishan International Conference Center.

Caption

On the afternoon of October 29, Dr. Ren will deliver two presentation sessions illustrating Insilico Medicine’s successful journey from "hardcore technology" to "commercialization and capital markets."

Credit

Insilico Medicine

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.